FiercePharma20d
Merck KGaA's EMD Serono taps Selma Blair to join long-running campaign for MS drug Mavenclad
No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. Blair, best known for her roles in turn ...
pharmaphorum1mon
Regulators finally back Merck KGaA oral MS drug
Europe’s CHMP top scientific committee gave a positive opinion for approval to cladribine, with the proposed trade name Mavenclad, for relapsing forms of MS with high disease activity.
Healthline7y
What’s the Difference Between Oral, Injectable, and Infusable MS Treatments?
There are many treatment options for multiple sclerosis (MS). For medications, they may be injected, infused, or swallowed. Multiple sclerosis (MS) is an autoimmune disorder in which the body’s ...
pharmaphorum7y
NHS England chief hails ‘precedent setting’ outcomes deal with Merck
The second deal is with German pharma company Merck for its multiple sclerosis drug Mavenclad (cladribine), and involves a new outcomes-based pricing agreement. Simon Stevens hailed the Merck ...